Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$RNTX

Rein Therapeutics, Inc. Common Stock

XNAS

$0.7354+2.94%+$0.0210Prev $0.7144LIVE Full chart Live alerts
No recent price bars, the chart lights up when RNTX starts printing.

Why is RNTX up today? It is at $0.735 (+2.94%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNTX spikes, and full due diligence on RNTX — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $RNTX alerts the moment volume spikes

Our scanner flagged $RNTX 5 times in the last 30 days. Create a free account to track $RNTX, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$0.735
Change today
+2.94%
Previous close
$0.714
52-week range
$0.694 – $2.18
Valuation & dividend
Market cap
$61M
Ownership & volume
Shares outstanding
85.5M
SEC · as of 2026-05-13 · 85d
Insider ownership
1.6%
DEF 14A · 2026-06-08
Institutional own.
14.74%
Total held
16.3%
Tradeable float
71.6M
84% of shares · after 2% insiders + 15% institutions
Short interest
879K
▼ -2% vs prior · as of 2026-07-15
Short % of float
1.2%
Days to cover
2.5d
Avg daily volume
531K
Next earnings
Aug 13 · in 7d
Classification
Exchange
XNAS
Relative volumevs this time of day
5m
0.3x
15m
0.1x
1h
0.1x
1D
0.1x

Get free RNTX + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $RNTX up today?

Here is the latest on RNTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystShareholder Vote, from the latest SEC filing. Read it →
Why is $RNTX moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profile📅 Earnings in 7dNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201
Wall Street consensusStrong Buy2 analysts
Avg target $6.00(+716% upside)
Range $4 – $8
2 buy0 hold0 sell

Analyst data via Nasdaq. Not investment advice.

Insiders

Insiders buying10 open-market buys4 buys, 0 sells last 3 months (9/0 over 12 months)
Show 10 recent transactions
InsiderActionShares% of positionOwns afterValueDate
Von Rickenbach Josef H
Director
Bought (open market)+5Kadded 7.8%63K$5K
at $1.07
May 27, 26
Von Rickenbach Josef H
Director
Bought (open market)+23K
0.03% of company
added 67%58K$25K
at $1.06
May 26, 26
Von Rickenbach Josef H
Director
Bought (open market)+16K
0.02% of company
added 85%35K$17K
at $1.05
May 22, 26
Von Rickenbach Josef H
Director
Bought (open market)+3Kadded 22%19K$4K
at $1.04
May 21, 26
Windsor James Brian
Officer
Bought (open market)+25K
0.03% of company
added 100%27K$25K
at $1.00
Apr 30, 26
Voss Capital, Lp
Beneficial Owner (10%)
Bought (open market)+104K
0.1% of company
added 7.9%1.43M$127K
at $1.22
Nov 14, 25
Voss Capital, Lp
Beneficial Owner (10%)
Bought (open market)+178K
0.2% of company
added 16%1.32M$248K
at $1.39
Oct 28, 25
Voss Capital, Lp
Beneficial Owner (10%)
Bought (open market)+97K
0.1% of company
added 13%822K$134K
at $1.37
Oct 27, 25
Voss Capital, Lp
Beneficial Owner (10%)
Bought (open market)+30K
0.04% of company
added 4.3%730K$42K
at $1.39
Oct 24, 25
Windsor James Brian
Officer
Bought (open market)+400n/a225$896
at $2.24
Dec 5, 24

Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.

Dilution watch

Recent offering

At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $RNTX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$RNTX Sentiment

Bullish
Bearish86Bullish
📰 News: 4 bull · 0 bearToday: +2.9%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$RNTX Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 20h ago -1.64%
$RNTX moved -1.64% in 1 min (Level 1) at 2:36 PM ET
at $0.719
Alert· 20h ago 92.4× RVOL
RNTX hit 92.395x RVOL at 2:36 PM ET
at $0.725
Alert· 13d ago -1.02%
$RNTX moved -1.02% in 1 min (Level 1) at 1:11 PM ET
at $0.806
Alert· 13d ago -2.3% vs EMA
$RNTX near 200 EMA: -2.31% from 200 EMA at 1:11 PM ET
at $0.806
Alert· 13d ago 125.8× RVOL
RNTX hit 125.782x RVOL at 1:11 PM ET
at $0.806
Alert· 14d ago +3.05%
$RNTX moved +3.05% in 1 min (Level 3) at 10:58 AM ET
at $0.763
News· SEC EDGAR· 15d ago
Rein Therapeutics, Inc. filed an 8-K: Shareholder Vote
News· Benzinga· 80d ago Bullish
Rein Therapeutics Announces Closing of $57.5 Million Underwritten Public Offering, Including Full Exercise of Over-Allotment Option
News· SEC EDGAR· 83d ago
Rein Therapeutics, Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 93d ago
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
News· GlobeNewswire Inc.· 97d ago Bullish
Rein Therapeutics Announces Pricing of $50 Million Underwritten Public Offering of Common Stock
News· SEC EDGAR· 101d ago
Rein Therapeutics, Inc. filed a Annual report (10-K/A)
News· GlobeNewswire Inc.· 177d ago Bullish
Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight
News· GlobeNewswire Inc.· 352d ago Bullish
Rein Therapeutics Wins U.K. Approval to Launch Phase 2 Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

RNTX stock FAQ

Why is $RNTX up today?

Here is the latest on RNTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the RNTX stock price today?

RNTX last traded at $0.735, up 2.94% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does RNTX report earnings?

Rein Therapeutics, Inc. Common Stock (RNTX) is next expected to report earnings on Thursday, August 13, 2026, about 7 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live RNTX alerts?

The RNTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNTX 5 times in the last 30 days.

What exchange is RNTX on?

RNTX (Rein Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $61M.

Is RNTX good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNTX for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.